Predictmedix AI Announces Closing of Final Tranche of Non-Brokered Private Placement

Executive Summary

• Predictmedix AI Inc. closed the final tranche of its non‑brokered private placement, issuing 3,050,000 units at $0.05 per unit for gross proceeds of $152,500.
• The total capital raised across all tranches now totals $612,650.
• Each unit includes one common share and half a warrant; warrants allow purchase of half a share at C$0.15 for 36 months, with an acceleration clause tied to the CSE price performance.

Key Details

• Units Issued (Final Tranche): 3,050,000 units @ $0.05 per unit → Gross proceeds: $152,500.
• Cumulative Proceeds: $612,650 raised from all tranches of the offering.
• Unit Composition: 1 common share + ½ common share purchase warrant per unit.
• Warrant Terms:
• Exercise price: C$0.15 per half‑share.
• Term: 36 months from closing date.
• Acceleration clause: If, after four months + one day, the VWAP of Predictmedix common shares on the CSE ≥ $0.30 for any 10 consecutive trading days, the company may accelerate expiry to 30 days after written notice.
• Statutory Hold Period: All securities subject to a hold period of four months and one day from issuance date.
• Strategic Rationale (COO Quote): Financing completed with strategic participants to preserve share‑structure integrity, limit dilution, and bring expertise/network value rather than maximizing capital.

Notable Quotes

“We are pleased to complete this financing with a select group of strategic participants who align closely with our long‑term vision… With this measured financing now concluded, we are moving ahead with clarity and strong momentum as we continue advancing our initiatives across key markets.” – Dr. Rahul Kushwah, COO, Predictmedix AI

Materiality Assessment: Material – Positive (significant capital raise supporting ongoing operations and strategic growth).